HEADER TRANSCRIPTION/INHIBITOR 24-AUG-19 6U4A TITLE BRD3-BD1 IN COMPLEX WITH THE CYCLIC PEPTIDE 3.1_3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 3; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: RING3-LIKE PROTEIN; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: CYCLIC PEPTIDE 3.1_3; COMPND 8 CHAIN: D, C; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD3, KIAA0043, RING3L; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 32630 KEYWDS BET, BROMODOMAIN, MACROCYCLIC PEPTIDE, BRD3, INHIBITOR, RAPID, KEYWDS 2 TRANSCRIPTION-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.PATEL,J.L.WALSHE,L.J.WALPORT,J.P.MACKAY REVDAT 4 15-NOV-23 6U4A 1 REMARK REVDAT 3 11-OCT-23 6U4A 1 REMARK REVDAT 2 03-MAR-21 6U4A 1 JRNL REVDAT 1 19-AUG-20 6U4A 0 JRNL AUTH K.PATEL,L.J.WALPORT,J.L.WALSHE,P.D.SOLOMON,J.K.K.LOW, JRNL AUTH 2 D.H.TRAN,K.S.MOURADIAN,A.P.G.SILVA,L.WILKINSON-WHITE, JRNL AUTH 3 A.NORMAN,C.FRANCK,J.M.MATTHEWS,J.M.GUSS,R.J.PAYNE, JRNL AUTH 4 T.PASSIOURA,H.SUGA,J.P.MACKAY JRNL TITL CYCLIC PEPTIDES CAN ENGAGE A SINGLE BINDING POCKET THROUGH JRNL TITL 2 HIGHLY DIVERGENT MODES. JRNL REF PROC.NATL.ACAD.SCI.USA V. 117 26728 2020 JRNL REFN ESSN 1091-6490 JRNL PMID 33046654 JRNL DOI 10.1073/PNAS.2003086117 REMARK 2 REMARK 2 RESOLUTION. 1.88 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.88 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.82 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 23024 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.165 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.188 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1150 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 3.7600 - 2.9900 1.00 2795 128 0.1587 0.1693 REMARK 3 2 2.9900 - 2.6100 1.00 2728 154 0.1744 0.2125 REMARK 3 3 2.6100 - 2.3700 1.00 2700 155 0.1659 0.1941 REMARK 3 4 2.3700 - 2.2000 1.00 2710 144 0.1593 0.1986 REMARK 3 5 2.2000 - 2.0700 1.00 2721 134 0.1586 0.2026 REMARK 3 6 2.0700 - 1.9700 1.00 2678 143 0.1751 0.2234 REMARK 3 7 1.9700 - 1.8800 0.99 2649 138 0.1954 0.2836 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.184 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.401 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.27 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 2367 REMARK 3 ANGLE : 0.674 3208 REMARK 3 CHIRALITY : 0.042 330 REMARK 3 PLANARITY : 0.004 409 REMARK 3 DIHEDRAL : 13.705 1427 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6U4A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-SEP-19. REMARK 100 THE DEPOSITION ID IS D_1000243895. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-FEB-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23076 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.880 REMARK 200 RESOLUTION RANGE LOW (A) : 43.840 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.88 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3S91 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM SULFATE 0.1 M BIS-TRIS REMARK 280 PROPANE 8.5 20 % W/V PEG 3350, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.41250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.82400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.20950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.82400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.41250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.20950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1580 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 20 REMARK 465 PRO A 21 REMARK 465 LEU A 22 REMARK 465 GLY A 23 REMARK 465 SER A 24 REMARK 465 GLU A 25 REMARK 465 VAL A 26 REMARK 465 SER A 27 REMARK 465 GLN B 20 REMARK 465 PRO B 21 REMARK 465 LEU B 22 REMARK 465 GLY B 23 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 LYS B 31 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLN A 61 CG CD OE1 NE2 REMARK 480 LYS A 117 CE NZ REMARK 480 PHE B 55 CG CD1 CD2 CE1 CE2 CZ REMARK 480 ALY D 9 CH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU B 70 75.09 -117.58 REMARK 500 ALY D 6 -36.93 77.29 REMARK 500 ALY C 6 -31.25 75.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE C 0 and TRP C 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE C 0 and CYS C 11 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide PRO C 5 and ALY C 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ALY C 6 and VAL C 7 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide LYS C 8 and ALY C 9 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ALY C 9 and GLY C 10 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide CYS C 11 and NH2 C REMARK 800 12 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE D 0 and CYS D 11 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE D 0 and TRP D 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide PRO D 5 and ALY D 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ALY D 6 and VAL D 7 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide LYS D 8 and ALY D 9 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ALY D 9 and GLY D 10 REMARK 800 REMARK 800 SITE_IDENTIFIER: AE1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide CYS D 11 and NH2 D REMARK 800 12 DBREF 6U4A A 25 147 UNP Q15059 BRD3_HUMAN 25 147 DBREF 6U4A B 25 147 UNP Q15059 BRD3_HUMAN 25 147 DBREF 6U4A D 0 12 PDB 6U4A 6U4A 0 12 DBREF 6U4A C 0 12 PDB 6U4A 6U4A 0 12 SEQADV 6U4A GLN A 20 UNP Q15059 EXPRESSION TAG SEQADV 6U4A PRO A 21 UNP Q15059 EXPRESSION TAG SEQADV 6U4A LEU A 22 UNP Q15059 EXPRESSION TAG SEQADV 6U4A GLY A 23 UNP Q15059 EXPRESSION TAG SEQADV 6U4A SER A 24 UNP Q15059 EXPRESSION TAG SEQADV 6U4A GLN B 20 UNP Q15059 EXPRESSION TAG SEQADV 6U4A PRO B 21 UNP Q15059 EXPRESSION TAG SEQADV 6U4A LEU B 22 UNP Q15059 EXPRESSION TAG SEQADV 6U4A GLY B 23 UNP Q15059 EXPRESSION TAG SEQADV 6U4A SER B 24 UNP Q15059 EXPRESSION TAG SEQRES 1 A 128 GLN PRO LEU GLY SER GLU VAL SER ASN PRO SER LYS PRO SEQRES 2 A 128 GLY ARG LYS THR ASN GLN LEU GLN TYR MET GLN ASN VAL SEQRES 3 A 128 VAL VAL LYS THR LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 4 A 128 PHE TYR GLN PRO VAL ASP ALA ILE LYS LEU ASN LEU PRO SEQRES 5 A 128 ASP TYR HIS LYS ILE ILE LYS ASN PRO MET ASP MET GLY SEQRES 6 A 128 THR ILE LYS LYS ARG LEU GLU ASN ASN TYR TYR TRP SER SEQRES 7 A 128 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 8 A 128 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 9 A 128 LEU MET ALA GLN ALA LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 10 A 128 VAL ALA GLN MET PRO GLN GLU GLU VAL GLU LEU SEQRES 1 B 128 GLN PRO LEU GLY SER GLU VAL SER ASN PRO SER LYS PRO SEQRES 2 B 128 GLY ARG LYS THR ASN GLN LEU GLN TYR MET GLN ASN VAL SEQRES 3 B 128 VAL VAL LYS THR LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 4 B 128 PHE TYR GLN PRO VAL ASP ALA ILE LYS LEU ASN LEU PRO SEQRES 5 B 128 ASP TYR HIS LYS ILE ILE LYS ASN PRO MET ASP MET GLY SEQRES 6 B 128 THR ILE LYS LYS ARG LEU GLU ASN ASN TYR TYR TRP SER SEQRES 7 B 128 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 8 B 128 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 9 B 128 LEU MET ALA GLN ALA LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 10 B 128 VAL ALA GLN MET PRO GLN GLU GLU VAL GLU LEU SEQRES 1 D 13 ACE TRP TRP ILE ILE PRO ALY VAL LYS ALY GLY CYS NH2 SEQRES 1 C 13 ACE TRP TRP ILE ILE PRO ALY VAL LYS ALY GLY CYS NH2 HET ACE D 0 3 HET ALY D 6 12 HET ALY D 9 12 HET NH2 D 12 1 HET ACE C 0 3 HET ALY C 6 12 HET ALY C 9 12 HET NH2 C 12 1 HET SO4 A 201 5 HET GOL A 202 6 HET SO4 B 201 5 HET GOL B 202 6 HET GOL B 203 6 HETNAM ACE ACETYL GROUP HETNAM ALY N(6)-ACETYLLYSINE HETNAM NH2 AMINO GROUP HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 ACE 2(C2 H4 O) FORMUL 3 ALY 4(C8 H16 N2 O3) FORMUL 3 NH2 2(H2 N) FORMUL 5 SO4 2(O4 S 2-) FORMUL 6 GOL 3(C3 H8 O3) FORMUL 10 HOH *206(H2 O) HELIX 1 AA1 THR A 36 VAL A 45 1 10 HELIX 2 AA2 VAL A 45 LYS A 52 1 8 HELIX 3 AA3 ALA A 56 TYR A 60 5 5 HELIX 4 AA4 ASP A 72 ILE A 77 1 6 HELIX 5 AA5 ASP A 82 ASN A 92 1 11 HELIX 6 AA6 SER A 97 ASN A 116 1 20 HELIX 7 AA7 ASP A 120 GLN A 139 1 20 HELIX 8 AA8 THR B 36 VAL B 45 1 10 HELIX 9 AA9 VAL B 45 LYS B 52 1 8 HELIX 10 AB1 ALA B 56 TYR B 60 5 5 HELIX 11 AB2 ASP B 72 ILE B 77 1 6 HELIX 12 AB3 ASP B 82 ASN B 92 1 11 HELIX 13 AB4 SER B 97 ASN B 116 1 20 HELIX 14 AB5 ASP B 120 GLN B 139 1 20 SHEET 1 AA1 2 TRP D 2 ILE D 4 0 SHEET 2 AA1 2 LYS D 8 ALY D 9 -1 O LYS D 8 N ILE D 3 SHEET 1 AA2 2 TRP C 2 ILE C 4 0 SHEET 2 AA2 2 LYS C 8 ALY C 9 -1 O LYS C 8 N ILE C 3 LINK C ACE D 0 N TRP D 1 1555 1555 1.33 LINK CH3 ACE D 0 SG CYS D 11 1555 1555 1.77 LINK C PRO D 5 N ALY D 6 1555 1555 1.33 LINK C ALY D 6 N VAL D 7 1555 1555 1.33 LINK C LYS D 8 N ALY D 9 1555 1555 1.33 LINK C ALY D 9 N GLY D 10 1555 1555 1.33 LINK C CYS D 11 N NH2 D 12 1555 1555 1.33 LINK C ACE C 0 N TRP C 1 1555 1555 1.33 LINK CH3 ACE C 0 SG CYS C 11 1555 1555 1.77 LINK C PRO C 5 N ALY C 6 1555 1555 1.34 LINK C ALY C 6 N VAL C 7 1555 1555 1.33 LINK C LYS C 8 N ALY C 9 1555 1555 1.33 LINK C ALY C 9 N GLY C 10 1555 1555 1.33 LINK C CYS C 11 N NH2 C 12 1555 1555 1.33 SITE 1 AC1 4 HIS A 53 GLN A 54 PHE A 55 GLN B 139 SITE 1 AC2 7 LYS A 31 ARG A 34 TRP A 96 LYS A 131 SITE 2 AC2 7 GLU A 146 HOH A 308 SER B 99 SITE 1 AC3 2 HIS B 53 GLN B 54 SITE 1 AC4 7 VAL B 26 SER B 27 LYS B 35 GLN B 40 SITE 2 AC4 7 ASN B 44 HOH B 313 HOH B 368 SITE 1 AC5 6 ASN B 37 GLN B 40 TYR B 41 HOH B 351 SITE 2 AC5 6 TRP C 1 CYS C 11 SITE 1 AC6 8 TRP A 57 ASN B 37 GOL B 203 TRP C 2 SITE 2 AC6 8 ALY C 9 GLY C 10 CYS C 11 HOH C 107 SITE 1 AC7 9 TRP A 57 HOH A 326 PRO B 141 GOL B 203 SITE 2 AC7 9 TRP C 1 ALY C 9 GLY C 10 NH2 C 12 SITE 3 AC7 9 HOH C 107 SITE 1 AC8 12 VAL A 63 LEU A 68 ASN A 116 ASP A 120 SITE 2 AC8 12 ASP A 121 ILE A 122 HOH A 316 HOH A 328 SITE 3 AC8 12 TRP C 2 ILE C 4 VAL C 7 HOH C 101 SITE 1 AC9 12 VAL A 63 ASN A 116 ASP A 120 ASP A 121 SITE 2 AC9 12 ILE A 122 HOH A 316 HOH A 328 TRP C 2 SITE 3 AC9 12 ILE C 4 PRO C 5 LYS C 8 HOH C 108 SITE 1 AD1 16 ASP A 121 MET A 125 GLN A 142 GLU A 143 SITE 2 AD1 16 HOH A 301 GLN B 142 GLU B 143 TRP C 1 SITE 3 AD1 16 TRP C 2 ILE C 3 ILE C 4 VAL C 7 SITE 4 AD1 16 GLY C 10 CYS C 11 HOH C 103 HOH C 106 SITE 1 AD2 13 ASP A 121 MET A 125 GLN A 142 GLU A 143 SITE 2 AD2 13 ASN B 37 PRO B 141 TRP C 1 TRP C 2 SITE 3 AD2 13 ILE C 3 LYS C 8 CYS C 11 HOH C 103 SITE 4 AD2 13 HOH C 106 SITE 1 AD3 9 TRP A 57 HOH A 326 HOH A 333 PRO B 141 SITE 2 AD3 9 GOL B 203 ACE C 0 TRP C 1 ALY C 9 SITE 3 AD3 9 GLY C 10 SITE 1 AD4 11 PRO A 29 SER A 30 GLU B 25 TRP B 57 SITE 2 AD4 11 TRP D 1 ALY D 9 GLY D 10 NH2 D 12 SITE 3 AD4 11 HOH D 101 HOH D 104 HOH D 107 SITE 1 AD5 11 PRO A 29 SER A 30 LYS A 31 TRP B 57 SITE 2 AD5 11 TRP D 2 ILE D 3 ALY D 9 GLY D 10 SITE 3 AD5 11 CYS D 11 HOH D 101 HOH D 104 SITE 1 AD6 12 VAL B 63 LEU B 68 ASN B 116 ASP B 120 SITE 2 AD6 12 ASP B 121 ILE B 122 HOH B 322 HOH B 350 SITE 3 AD6 12 TRP D 2 ILE D 4 VAL D 7 HOH D 102 SITE 1 AD7 12 VAL B 63 ASN B 116 LYS B 117 ASP B 120 SITE 2 AD7 12 ASP B 121 ILE B 122 HOH B 322 HOH B 350 SITE 3 AD7 12 TRP D 2 ILE D 4 PRO D 5 LYS D 8 SITE 1 AD8 15 ASN A 28 SER B 24 GLN B 54 TRP B 57 SITE 2 AD8 15 ASP B 121 MET B 125 TRP D 1 TRP D 2 SITE 3 AD8 15 ILE D 3 ILE D 4 VAL D 7 GLY D 10 SITE 4 AD8 15 CYS D 11 NH2 D 12 HOH D 107 SITE 1 AD9 13 ASN A 28 SER B 24 GLU B 25 GLN B 54 SITE 2 AD9 13 TRP B 57 ASP B 121 MET B 125 TRP D 1 SITE 3 AD9 13 ILE D 3 LYS D 8 CYS D 11 NH2 D 12 SITE 4 AD9 13 HOH D 107 SITE 1 AE1 9 ASN A 28 PRO A 29 GLU B 25 TRP B 57 SITE 2 AE1 9 ACE D 0 TRP D 1 ALY D 9 GLY D 10 SITE 3 AE1 9 HOH D 107 CRYST1 48.825 64.419 87.648 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020481 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015523 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011409 0.00000